SC 13G/A

AMENDMENT NO. 5 TO THE SCHEDULE 13G

Company: Corvus Pharmaceuticals, Inc.
Filed: February 12, 2021
Accession Number: 0000921895-21-000376

View Document ↗ View on SEC.gov ↗